Blanket Purchase Agreement V797P5497X-HHSI249200810016B

The federal contract IDV award is for an Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp as the prime contractor. The contract, valued at $999,999,999, covers the provision of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test...

The federal contract IDV award is for an Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $999,999,999, provides worldwide pharmaceutical support to various Department of Defense (DoD) customers, including the Defense Health Agency, the U.S. Coast Guard, and U.S. Naval Fleet. The contract covers a broad...

The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp. The contract has a ceiling value of $999,999,999 and a period of performance through December 31, 2036. It serves as a prime vendor arrangement to provide worldwide pharmaceutical support, including brand-name and generic drugs, specialty medications, vaccines, medical devices, and other related...

The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) to The Harvard Drug Group, L.L.C., a subsidiary of Cardinal Health, Inc., for the supply of Bupropion Hydrochloride (HCL) Tablets in 100mg and 75mg dosages. The contract, valued at $2,936,792.25, has a base period of performance from March 1, 2025, to February 28, 2026, with four one-year option periods. The contracted items will be distributed through the VA's and...

The federal contract IDV award is an Indefinite Delivery Contract (IDC) valued at $9,999,999,999 awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp. The contract provides a comprehensive range of pharmaceutical and medical supplies to support military healthcare programs globally. The contract covers an extensive array of medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits...

The U.S. Department of Veterans Affairs (VA) awarded an Indefinite Delivery Contract (IDC) to The American National Red Cross, doing business as American Red Cross, a major supplier of blood and blood products to the federal government. The $331,324.59 contract, which is not set aside, has an ultimate completion date of November 30, 2026. Under this IDC, the American Red Cross will provide critical blood products, including whole blood, blood components, and specialized laboratory services, to...

This federal contract IDV award was issued by the Centers for Disease Control and Prevention (CDC) to procure pediatric vaccines for the Vaccines for Children (VFC) program. The 5-year, $1.35 billion multiple award contract aims to purchase standard commercial pediatric vaccines to support immunization efforts for eligible children, including those who are Medicaid-eligible, uninsured, American Indian/Alaska Native, or have insurance that does not cover vaccines. The prime contractor,...

The National Prime Vendor contract will provide pharmaceutical products and related services to multiple TRICARE Mail Order Pharmacy and TRICARE Specialty Pharmacy Network ordering facilities in support of the Defense Health Agency's TRICARE Pharmacy Program. Amerisourcebergen Drug Corporation will serve as the prime vendor, delivering products from distribution centers including a location in Conshohocken, Pennsylvania. Delivery orders issued against the contract, valued at amounts ranging from...

The Department of Veterans Affairs Veterans Health Administration awarded a multiple-award Federal Supply Schedule contract to Biocon Biologics Inc., a foreign-owned, for-profit manufacturer of goods. The contract provides an interim agreement under FSS Schedule 65 I B for drugs, pharmaceuticals, and hematology-related products. The potential value of the contract is $25 million. Delivery orders may be placed under the contract through February 2029. The contract facilitates procurement of...

The federal contract IDV awarded to Amgen USA Inc., a division of the biotechnology company Amgen Inc., is primarily focused on supplying calcitonin gene-related peptide (CGRP) agents to the Department of Veterans Affairs (VA), Bureau of Prisons (BOP), and Indian Health Service (IHS). The original solicitation, RFP 36E79719R0025 issued by the VA National Acquisition Center, sought a one-year contract with four one-year option periods to provide Erenumab-aooe, Fremanezumab-vfrm, and...